Germany
Japan
United Kingdom
China
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 9G5-20
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
View as table Download
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 12G4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 15C4-8
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 16F12-11
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD3 epsilon (Clone 145-2C11)
| Applications | FC, IP, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD200R (Clone OX108)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD3 epsilon (Clone 500A2)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
| Applications | FC |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD34 (Clone My10)
| Applications | FC, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD38 (Clone HB7)
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone G28.5)
| Applications | FC, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-DC-SIGNR (Clone 16E7)
| Applications | FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-P-glycoprotein (Clone MRK16)
| Applications | FC, IF, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-4 (Clone 11B11)
| Applications | ELISA, FC, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD52 (Clone YTH 34.5-G2b (Campath-1G))
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-VAP-1 (Clone 2D10)
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IFN gamma (Clone D9D10)
| Applications | ELISA, FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-HLA class II (Clone F3.3)
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 523.00
5 Weeks
Recombinant Anti-IL-2R (Clone Daclizumab)
| Applications | FC |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
USD 523.00
2 Weeks
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Alpha-fetoprotein (AFP) (Clone AF5)
| Applications | FC, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD19 (Clone HD37)
| Applications | FC, IF, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone MT310)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-CD19 (Clone 4G7)
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone 13B8.2)
| Applications | EIA, ELISA, FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-EGFR (Clone C225 (Cetuximab))
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD33 (Clone hP67.6 (Gemtuzumab))
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD28 (Clone JJ316)
| Applications | FC, IF, IHC |
| Reactivities | Rat |
| Conjugation | Unconjugated |
Recombinant Anti-CD28 (Clone D665)
| Applications | FC, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD32 (Clone AT10)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD38 (Clone AT13/5)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD79a (Clone ZL7-4)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IgM (Clone M15/8)
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-C3a-receptor (Clone 3G7)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD63 (Clone MOF11)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Human Ephrin Type A receptor 2 (Clone 1C1)
| Applications | ELISA, FC, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-SIRP- beta & gamma (Clone OX117)
| Applications | ELISA, FC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Category
-
Antibodies
- Primary Antibodies
Applications
- FC
Isotypes
- IgG1, kappa
Conjugates
- Unconjugated
Filter by
Target Symbol
- ERBB2 (22)
- EGFR (7)
- IL2RA (7)
- CD276 (6)
- LAG3 (6)
- CD28 (4)
- CD4 (4)
- CD38 (3)
- CD3E (3)
- CD81 (3)
- MS4A1 (3)
- AKT1 (2)
- CD19 (2)
- CD40 (2)
- CD40LG (2)
- CD52 (2)
- CD63 (2)
- CD74 (2)
- FCER1G (2)
- TAG72 (2)
- TIMD4 (2)
- VEGFA (2)
- ABCB1 (1)
- ACKR1 (1)
- ADRB2 (1)
- AFP (1)
- AGER (1)
- AOC3 (1)
- APOA5 (1)
- APOE (1)
- ATP1A1 (1)
- C3AR1 (1)
- CD16 (1)
- CD1A (1)
- CD200R1 (1)
- CD22 (1)
- CD274 (1)
- CD33 (1)
- CD34 (1)
- CD37 (1)
- CD53 (1)
- CD8A (1)
- CEA (1)
- CHUK (1)
- CLEC4A (1)
- CLEC4M (1)
- CR1 (1)
- CSPG4 (1)
- CXCR2 (1)
- DNMT3A (1)
- EPCAM (1)
- EPHA2 (1)
- FAS (1)
- FCAR (1)
- FCGR1A (1)
- FCGR2B (1)
- FOXP3 (1)
- G1 (1)
- HAVCR2 (1)
- HLA CLASS II (1)
- IFNG (1)
- IGM (1)
- IL10RA (1)
- IL17F (1)
- IL25 (1)
- IL4 (1)
- IL9 (1)
- ITGA2B (1)
- ITGA4 (1)
- ITGA5 (1)
- ITGAL (1)
- ITGAM (1)
- KRT7 (1)
- L1CAM (1)
- LAMP2 (1)
- MME (1)
- MS4A4A (1)
- MUC1 (1)
- NCR3LG1 (1)
- NES (1)
- NFKBIA (1)
- NOTCH1 (1)
- RELA (1)
- RORC (1)
- SELL (1)
- SIRPG (1)
- SNCA (1)
- SOX2 (1)
- TCR (1)
- TERF2 (1)
- TF (1)
- TLR3 (1)
- TLR9 (1)
- TNF (1)
- TNFAIP3 (1)
- TNFRSF10B (1)
- TNFRSF11A (1)
- TNFRSF11B (1)
- TNFRSF8 (1)
- TNFRSF9 (1)
Reactivities
Antibody Hosts
Clonalities
Modifications
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (9)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (44)
- Transmembrane (39)
- Protein Kinase (22)
- ES Cell Differentiation/IPS (6)
- Secreted Protein (5)
- Transcription Factors (5)
- Adult stem cells (4)
- Cancer stem cells (3)
- Embryonic stem cells (1)
- Induced pluripotent stem cells (1)
- Stem cell - Pluripotency (1)
- Stem cell relevant signaling - DSL/Notch pathway (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
Pathways
- Pathways in cancer (24)
- Prostate cancer (24)
- Pancreatic cancer (23)
- Adherens junction (21)
- Bladder cancer (21)
- Calcium signaling pathway (21)
- Endometrial cancer (21)
- ErbB signaling pathway (21)
- Focal adhesion (21)
- Non-small cell lung cancer (21)
- Cell adhesion molecules (CAMs) (5)
- Toll-like receptor signaling pathway (5)
- B cell receptor signaling pathway (4)
- Cytokine-cytokine receptor interaction (4)
- Epithelial cell signaling in Helicobacter pylori infection (4)
- NOD-like receptor signaling pathway (4)
- Adipocytokine signaling pathway (3)
- Apoptosis (3)
- Chemokine signaling pathway (3)
- Chronic myeloid leukemia (3)
- Cytosolic DNA-sensing pathway (3)
- MAPK signaling pathway (3)
- RIG-I-like receptor signaling pathway (3)
- Small cell lung cancer (3)
- T cell receptor signaling pathway (3)
- Acute myeloid leukemia (2)
- Alzheimer's disease (2)
- Dorso-ventral axis formation (2)
- Neurotrophin signaling pathway (2)
- Cardiac muscle contraction (1)
- Colorectal cancer (1)
- Cysteine and methionine metabolism (1)
- Endocytosis (1)
- Gap junction (1)
- Glioma (1)
- GnRH signaling pathway (1)
- Lysosome (1)
- Melanoma (1)
- Metabolic pathways (1)
- Notch signaling pathway (1)
- PPAR signaling pathway (1)
- Parkinson's disease (1)
- Prion diseases (1)
- Regulation of actin cytoskeleton (1)